Written Question·Department of Health and Social Care·UIN 98645

Trastuzumab Deruxtecan

Tabled: 9 December 2025
Answered: 17 December 2025

Question

Gregory Stafford

ConservativeFarnham and Bordon

To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of increasing the accessibility of Enhertu as a treatment for breast cancer.

Answer

Dr Zubir Ahmed
Decisions on whether new medicines should be routinely funded by the National Health Service in England are made on the basis of recommendations from the National Institute for Health and Care Excellence (NICE) following an evaluation of a treatment’s cos...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 98645) →